Vizora日本語

DenkaDenka Company Limited4061東証プライム化学FY ending Mar 2026, consolidated, J-GAAP

Denka FY ending Mar 2021 results

About 22% of Denka's sales come from Elastomers and Performance Plastics, with Polymer Solutions and Elastomers and Infrastructure Solutions making up much of the rest.

Out of every ¥100 of sales, about ¥10 is left as operating profit.

Revenue changed -6.9% from the prior year, operating profit +9.9%.

Revenue and profit pattern

Revenue down, profit up

Revenue -6.9% · profit +9.9%, calculated from disclosed figures.

Operating leverage: -1.43× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2020 → FY ending Mar 2021

Revenue
-6.9%¥380.8B → ¥354.4B
Gross profit
+0.9%¥99.3B → ¥100.2B
Operating income
+9.9%¥31.6B → ¥34.7B
Net income attributable to owners
+0.4%¥22.7B → ¥22.8B
Operating cash flow
-3.2%¥42B → ¥40.6B
Free cash flow
-61.6%¥8.12B → ¥3.12B

Where the money goes

FY ending Mar 2020 → FY ending Mar 2021

※ Segment revenues include inter-segment sales and are scaled to consolidated revenue

Where ¥100 of sales goes

For every ¥100 Denka sells, how much goes where, and how much is kept.

FY ending Mar 2021
Cost of sales
¥72
SG&A
¥18
Operating profit
¥10
Net profit kept
¥6

Annual margin trends

Gross margin28.3%
FY ending Mar 2020: 26.1%26.1%FY ending Mar 2021: 28.3%28.3%FY20FY21
Operating margin9.8%
FY ending Mar 2020: 8.3%8.3%FY ending Mar 2021: 9.8%9.8%FY20FY21
Net margin6.4%
FY ending Mar 2020: 6.0%6.0%FY ending Mar 2021: 6.4%6.4%FY20FY21

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2021
  • Elastomers and Performance Plastics¥124.3B
    22%
    Op. margin 3.6%
  • Polymer Solutions¥109.9B
    20%
    Op. margin 7.6%Industry: Chemicals
  • Elastomers and Infrastructure Solutions¥91.9B
    16%
    Op. margin -3.9%Industry: Chemicals
  • Electronics and Innovative Products¥77.7B
    14%
    Op. margin 18.3%Industry: Electronic Components
  • Infrastructure and Social Solutions¥50.5B
    9%
    Op. margin -1.1%
  • Life Innovation¥42.9B
    8%
    Op. margin 34.5%Industry: Pharmaceuticals
  • Life Science and Environment Products¥33.4B
    6%
    Op. margin 3.5%
  • Other¥32B
    6%
    Op. margin 2.2%

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (5)

  • EDINET (FSA Japan)

    有価証券報告書－第166期(2024/04/01－2025/03/31)

    ID S100VZX72025-06-19Open

  • EDINET (FSA Japan)

    有価証券報告書－第165期(2023/04/01－2024/03/31)

    ID S100TO952024-06-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第164期(2022/04/01－2023/03/31)

    ID S100R0XG2023-06-22Open

  • EDINET (FSA Japan)

    有価証券報告書－第163期(令和3年4月1日－令和4年3月31日)

    ID S100OC2H2022-06-22Open

  • EDINET (FSA Japan)

    有価証券報告書－第162期(令和2年4月1日－令和3年3月31日)

    ID S100LM7D2021-06-22Open

Extracted from XBRL: 55 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image